SMFG
BIIB icon

Sumitomo Mitsui Financial Group’s Biogen BIIB Stock Holding History

Sumitomo Mitsui Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-170
Closed -$45K – 173
2022
Q3 		$45K Buy
+170
New +$36.1K ﹤0.01% 174
2020
Q4 		– Sell
-632
Closed -$178K – 158
2020
Q3 		$178K Buy
+632
New +$176K 0.01% 123

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sumitomo Mitsui Financial Group's BIIB Position: Q4 2022 in Review

Sumitomo Mitsui Financial Group sold out of Biogen (BIIB) in Q4 2022, closing a stake of 170 shares — an estimated $45K sold.

Sumitomo Mitsui Financial Group first reported a position in BIIB in Q3 2020 and held it in 2 quarters. The position peaked at $178K in Q3 2020. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Sumitomo Mitsui Financial Group reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Sumitomo Mitsui Financial Group sold 170 Biogen shares in Q4 2022, an estimated $45K.
  • Sumitomo Mitsui Financial Group first reported a position in Biogen in Q3 2020 and held it in 2 quarters.
  • Sumitomo Mitsui Financial Group's Biogen position peaked at $178K in Q3 2020.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q4 2022, filed 10 Feb 2023.